NEW YORK, NY / ACCESSWIRE / September 12, 2017 / Markets rallied sharply Monday as damage from Hurricane Irma was less-than-expected. The Dow Jones Industrial Average spiked 1.19 percent to close at 22,057.37, its largest daily gain since March 1st, while the S&P 500 Index jumped 1.08 percent to close at a record 2,488.11, its largest daily gain since April 24th. The NASDAQ Composite Index rose 1.1 percent to close at 6,432.26. Hurricane Irma, previously categorized as a Category 5 hurricane, has now been downgraded to a Category 1 storm.

"It's basically a relief rally as there has been less damage from Hurricane Irma than expected and no rocket launches from North Korea. It is hard to understand why the simple lack of bad news is sending prices higher, but we must respect that fact - the momentum is still strong," said Wouter Sturkenboom, senior investment strategist at Russell Investments, according to MarketWatch.

RDI Initiates Coverage on:

Endo International plc (NASDAQ: ENDP) - https://rdinvesting.com/news/?ticker=ENDP

Valeant Pharmaceuticals Intl Inc. (NYSE: VRX) - https://rdinvesting.com/news/?ticker=VRX

Endo International's (NASDAQ: ENDP) stock jumped 6.42% Monday, to close the day at $9.28. The stock recorded a trading volume of 5,669,640 shares, which was below its three months average volume of 5,957,790 shares. In the last year, Endo International shares have traded in a range of 7.41 - 23.98. The share price has gained 25.19% from its 52-week low. The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $9.16 is below its 200-day moving average of $11.01. Shares of Endo International have fallen approximately 43.66 percent year-to-date.

Access RDI's Endo International plc Research Report at: https://rdinvesting.com/news/?ticker=ENDP

On Monday, shares in Valeant Pharmaceuticals (NYSE: VRX) recorded a trading volume of 12,727,937 shares, which was below the three months average volume of 17,239,700 shares. The stock ended the day 4.26% higher at 14.19. The share price has gained 70.74% from its 52-week low with a 52-week trading range of 8.31 - 29.57.The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $14.79 is greater than its 200-day moving average of $13.23. Shares of Valeant Pharmaceuticals have fallen approximately 2.27 percent year-to-date.

Access RDI's Valeant Pharmaceuticals Intl Inc. Research Report at: https://rdinvesting.com/news/?ticker=VRX

Our Actionable Research on Endo International plc (NASDAQ: ENDP) and Valeant Pharmaceuticals Intl Inc. (NYSE: VRX) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting